Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05928156 · ClinicalTrials.gov registry record · NA
Multiple Myeloma/Chronic Lymphocytic Leukemia Coach RCT
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT05928156 is a NA study that has completed, run by Duke University. The registered enrollment target is 77 participants.
The verdict
NCT05928156, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
The purpose of this study is to test the effectiveness of evidence-informed mobile apps, Myeloma Coach and CLL Coach. These apps have been developed to help manage the physical and emotional symptoms experienced by multiple myeloma and chronic lymphocytic leukemia survivors. This study hopes to determine if a mobile app is a useful tool to help people manage commonly reported symptoms related to Multiple Myeloma (MM) and chronic lymphocytic leukemia (CLL).
Interventions
- OTHER Myeloma Coach or CLL Coach Mobile App
- OTHER Springboard Beyond Cancer informational website
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2020-12-17 |
| Est. Completion | 2021-09-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05928156
The ClinicalTrials.gov registry entry for NCT05928156 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Myeloma Coach or CLL Coach Mobile App is the first listed.
NCT05928156 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05928156 about?
NCT05928156 is a clinical study titled "Multiple Myeloma/Chronic Lymphocytic Leukemia Coach RCT". The purpose of this study is to test the effectiveness of evidence-informed mobile apps, Myeloma Coach and CLL Coach. These apps have been developed to help manage the physical and emotional symptoms experienced by multiple myeloma and chronic lymphocytic leukemia survivors. This study hopes to dete...
What is the current status of trial NCT05928156?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2020-12-17. Estimated completion is 2021-09-19.
What interventions are being tested in trial NCT05928156?
The interventions under investigation include: Myeloma Coach or CLL Coach Mobile App (OTHER), Springboard Beyond Cancer informational website (OTHER).
Who is sponsoring clinical trial NCT05928156?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.